- Home
- Publications
- Publication Search
- Publication Details
Title
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 23, Issue 3, Pages 409-420
Publisher
Springer Science and Business Media LLC
Online
2022-05-03
DOI
10.1007/s40257-022-00684-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
- (2022) Marjolein S. de Bruin-Weller et al. Dermatology and Therapy
- JAK inhibitors for atopic dermatitis: a promising treatment modality
- (2021) A.M. Cartron et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy Phase 3 trial in the United States and Canada (BREEZE-AD5)
- (2021) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study
- (2021) Natalie N. Boytsov et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life, and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomised trial
- (2021) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders
- (2021) Jonathan I. Silverberg et al. JAMA Dermatology
- Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
- (2021) Timo Buhl et al. Dermatology and Therapy
- Baricitinib for the treatment of atopic dermatitis
- (2021) Amelia Melo et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection
- (2021) Mostafa Akbarzadeh-Khiavi et al. INFECTION
- 041 Efficacy with continuous dosing, down-titration, or treatment withdrawal after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis
- (2021) K. Reich et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials
- (2020) E.L. Simpson et al. BRITISH JOURNAL OF DERMATOLOGY
- New and Emerging Systemic Treatments for Atopic Dermatitis
- (2020) Megan Newsom et al. DRUGS
- Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials
- (2020) T. Bieber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis
- (2020) Kristian Reich et al. JAMA Dermatology
- Pharmacokinetics, Safety, and Tolerability of Single‐ and Multiple‐Dose Once‐Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo‐Controlled Study
- (2020) Xia Zhao et al. Clinical Pharmacology in Drug Development
- Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials
- (2020) K. Reich et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The role of filaggrin in atopic dermatitis and allergic disease
- (2019) Catherine Drislane et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Baricitinib: A Review in Rheumatoid Arthritis
- (2018) Zaina T. Al-Salama et al. DRUGS
- Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers
- (2014) Jack G. Shi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search